Dialysis Studies in Rats on the Long-Acting Antimalarial CI-501
J. A. Waitz 1,
B. J. Olszewski 1, and
P. E. Thompson 1
1 Research Division, Parke, Davis & Company, Ann Arbor, Michigan
Through the use of dialysis sacks, containing the repository antimalarial CI-501, implanted intraperitoneally into rats, evidence has been obtained indicating a local rather than a systemic reservoir of the drug. These results suggest that the repository activity of CI-501 is due to drug release from the injection site and that the probability of toxic effects resulting from storage or accumulation of the drug in vital organs is remote.